Catherine Behrens

2.8k total citations · 2 hit papers
31 papers, 2.1k citations indexed

About

Catherine Behrens is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Catherine Behrens has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 15 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Catherine Behrens's work include Cervical Cancer and HPV Research (25 papers), Genital Health and Disease (13 papers) and Molecular Biology Techniques and Applications (9 papers). Catherine Behrens is often cited by papers focused on Cervical Cancer and HPV Research (25 papers), Genital Health and Disease (13 papers) and Molecular Biology Techniques and Applications (9 papers). Catherine Behrens collaborates with scholars based in United States, Italy and United Kingdom. Catherine Behrens's co-authors include Thomas C. Wright, Mark H. Stoler, Teresa L. Wright, Abha Sharma, Guili Zhang, Philip E. Castle, Abha Sharma, Raymond Apple, J. Thomas Cox and Jack Cuzick and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Journal and The Lancet Oncology.

In The Last Decade

Catherine Behrens

31 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

2015 418 citations Thomas C. Wright, Mark H. Stoler et al. Gynecologic Oncology profile →
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

2011 391 citations Philip E. Castle, Mark H. Stoler et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Behrens United States	18	1.8k	922	442	419	283	31	2.1k
Deirdre Lyons United Kingdom	12	560 0.3×	223 0.2×	245 0.6×	84 0.2×	129 0.5×	21	696
S Costa Italy	17	508 0.3×	176 0.2×	161 0.4×	202 0.5×	43 0.2×	33	699
Roger Dachez France	11	533 0.3×	302 0.3×	134 0.3×	122 0.3×	82 0.3×	28	671
Louise Baandrup Denmark	16	543 0.3×	347 0.4×	72 0.2×	225 0.5×	55 0.2×	47	1.1k
M Branca Italy	15	460 0.3×	174 0.2×	151 0.3×	186 0.4×	48 0.2×	31	642
David C. Swan United States	13	412 0.2×	232 0.3×	289 0.7×	94 0.2×	79 0.3×	15	739
Lihui Wei China	17	415 0.2×	133 0.1×	262 0.6×	128 0.3×	35 0.1×	83	857
Eliano Cascardi Italy	15	131 0.1×	103 0.1×	196 0.4×	245 0.6×	48 0.2×	70	736
Fabio Bottari Italy	15	328 0.2×	155 0.2×	185 0.4×	85 0.2×	67 0.2×	38	629

Countries citing papers authored by Catherine Behrens

Since Specialization

Citations

This map shows the geographic impact of Catherine Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Behrens more than expected).

Fields of papers citing papers by Catherine Behrens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Behrens. The network helps show where Catherine Behrens may publish in the future.

Co-authorship network of co-authors of Catherine Behrens

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Behrens. A scholar is included among the top collaborators of Catherine Behrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Behrens. Catherine Behrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tewari, Devansu, Susan Novak-Weekley, Christina Hong, Shagufta Aslam, & Catherine Behrens. (2017). Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath. American Journal of Clinical Pathology. 148(5). 450–457. 7 indexed citations

Castle, Philip E., Shagufta Aslam, & Catherine Behrens. (2016). Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management. Cancer Epidemiology Biomarkers & Prevention. 25(12). 1595–1599. 15 indexed citations

Wright, Thomas C., Mark H. Stoler, Shagufta Aslam, & Catherine Behrens. (2016). Knowledge of Patients’ Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study. American Journal of Clinical Pathology. 146(3). 391–398. 20 indexed citations

Hardy, David C., et al.. (2016). Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid. Journal of Molecular Diagnostics. 19(2). 288–294. 5 indexed citations

Wright, Thomas C., Catherine Behrens, James Ranger‐Moore, et al.. (2016). Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Gynecologic Oncology. 144(1). 51–56. 107 indexed citations

Mbatani, Nomonde, Tracey Adams, Catherine Behrens, et al.. (2016). Performance of an Human Papillomavirus Test in Samples From Women With Histolopathologically Confirmed Invasive Cervical Cancer. Journal of Lower Genital Tract Disease. 20(2). 151–153. 7 indexed citations

Wright, Thomas C., Mark H. Stoler, Catherine Behrens, et al.. (2015). Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. Gynecologic Oncology. 136(2). 189–197. 418 indexed citations breakdown →

Monsonégo, Joseph, J. Thomas Cox, Catherine Behrens, et al.. (2015). Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial. Gynecologic Oncology. 137(1). 47–54. 121 indexed citations

Huh, Warner K., Catherine Behrens, Joseph Monsonégo, et al.. (2015). Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine. Gynecologic Oncology. 137. 16–16. 1 indexed citations

10.

Huh, Warner K., Mario Sideri, Mark H. Stoler, et al.. (2014). Relevance of Random Biopsy at the Transformation Zone When Colposcopy Is Negative. Obstetrics and Gynecology. 124(4). 670–678. 46 indexed citations

11.

Gage, Julia C., Hormuzd A. Katki, Mark Schiffman, et al.. (2014). The low risk of precancer after a screening result of human papillomavirus‐negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management. Cancer Cytopathology. 122(11). 842–850. 27 indexed citations

12.

Rao, Arundhati, et al.. (2013). Development and Characterization of the cobas Human Papillomavirus Test. Journal of Clinical Microbiology. 51(5). 1478–1484. 69 indexed citations

13.

Rao, Arundhati, Maria Teresa Sandri, Mario Sideri, et al.. (2013). Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study. Journal of Clinical Virology. 58(1). 161–167. 7 indexed citations

14.

Wright, Thomas W., Philip E. Castle, Catherine Behrens, & Warner K. Huh. (2013). Risk of ≥CIN3 after 3years of follow-up of 42,209 screened women: End of study results from ATHENA. Gynecologic Oncology. 130(1). e166–e166. 1 indexed citations

15.

Rao, Arundhati, et al.. (2012). Comparison of cobas human papillomavirus test results from primary versus secondary vials of PreservCyt specimens and evaluation of potential cross‐contamination. Cancer Cytopathology. 120(6). 380–389. 2 indexed citations

16.

Cuzick, Jack, J. Thomas Cox, Guili Zhang, et al.. (2012). Human papillomavirus testing for triage of women with low‐grade squamous intraepithelial lesions. International Journal of Cancer. 132(4). 959–966. 20 indexed citations

17.

Cox, J. Thomas, et al.. (2012). Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. American Journal of Obstetrics and Gynecology. 208(3). 184.e1–184.e11. 159 indexed citations

18.

Wright, Thomas C., et al.. (2011). The ATHENA human papillomavirus study: design, methods, and baseline results. American Journal of Obstetrics and Gynecology. 206(1). 46.e1–46.e11. 200 indexed citations

19.

Castle, Philip E., Mark H. Stoler, Thomas C. Wright, et al.. (2011). Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. The Lancet Oncology. 12(9). 880–890. 391 indexed citations breakdown →

20.

Behrens, Catherine & J. Ramachandran. (1981). The effect of glucocorticoids on adipocyte corticotropin receptors and adipocyte responses. Biochimica et Biophysica Acta (BBA) - General Subjects. 672(3). 268–279. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact